Skip links

info@visionofresearch.ae

14th Floor, Dubai Science Park South Tower - Al Barsha South - Dubai - UAE

+971 425 44824

Start a Project

Academic & Research Platforms

University & Discovery-Oriented Services

1.End-to-End Research Project Design

2.Scientific Positioning & Topic Strategy

3.Hypothesis & Research Question Engineering

4.Study Methodology & Experimental Workflow

5.Statistical Design & Power Analysis

6.Biomarker, Gene & Target Strategy

7.Assay Selection & Validation Planning

8.Translational & Regulatory Alignment

9.Risk Management, Quality & Reproducibility

10.Data Analysis, Reporting & Scientific Support

1.Neurology & Neuroscience

2.Metabolic & Endocrine Models

3.Cardiovascular & Stroke Models

4.Reproductive & Fertility Models

5.Immunology & Inflammation

6.Liver & Kidney Disease Models

7.Gastrointestinal & Microbiome

8.Regenerative & Wound Healing

9.Toxicology & Safety Models

10.Ocular & Retinal Disease Models

11.Respiratory Disease Models

12.Musculoskeletal & Arthritis Models

13.Urology & Renal Function Models

14.Ocular & Retinal Disease Models

1.Learning, Memory & Cognition

2.Anxiety & Stress Behavior Assessment

3.Depression & Motivation Behavior

4.Pain & Nociception Assessment

5.Motor Function & Coordination

6.Sensorimotor Integration & Reflexes

7.Seizure & Epilepsy-Related Behavior

8.Sleep & Circadian Rhythm

9.Social Behavior & Communication

10.Reward, Addiction & Motivation

11.Fatigue & Exercise Capacity

12.Gastrointestinal & Feeding Behavior

13.Metabolic & Energy Balance

14.Urinary & Bladder Function

15.Cardiovascular Function & Stroke

16.Regenerative Functional Readouts

17.General Activity, Locomotion

Clinical Monitoring

  • General Appearance & Condition
  • Behavior & Stress Indicators
  • Grooming & Coat Condition
  • Respiratory Patterns & Function
  • Toxicity & Distress Signs
  • Body Weight & Growth Monitoring
  • Food Intake & Nutritional Status
  • Hydration & Fluid Balance

Hematological & Biochemical

  • Complete Blood Count (CBC)
  • Clinical Biochemistry Panels
  • Electrolyte

1.Gene Expression (PCR-based)

2.Nucleic Acid Extraction & Synthesis

3.Design of Nucleotide Primer Sequences

4.PCR & Advanced Molecular Analysis 

5.DNA & RNA Quantification

6.Agarose Gel Electrophoresis Performance

7.Epigenetic and DNA Methylation Assays

8.Transcriptomic and RNA-Seq Analysis

9.CRISPR-Based Genetic Validation Assays

10.Protein Expression (WB)

11.Biomarker Quantification (ELISA)

1.Cell Line Preparation & Treatment

2.Cell Viability, Proliferation & Cytotoxicity

3.Cell Migration, Invasion & Angiogenesis

4.Flow Cytometry & Cell Fate Analysis

5.Oxidative Stress & Drug Response

6.Cell Labeling, Tracking & Differentiation

7.Imaging & Microscopy

8.Organ-on-a-Chip & Advanced In-Vitro Models

9.Advanced Cellular & Molecular Platforms

10.Protein, Antibody & Omics-Related Services

1.IHC, IF & TUNEL assay

2.Fluorescent Staining Techniques

3.Specialized Staining Techniques

  • Structural and Morphological Tissue
  • Fibrosis and Extracellular Matrix
  • Neurodegeneration & Neural Integrity
  • Metabolic Changes & Lipid Accumulation
  • Mineralization and Calcification
  • Vascular Structure and Elastic Fibers
  • Inflammation & Immune Response
  • Vital Function & Cellular Differentiation
  • Microbiological Staining Techniques
  • Microscopic Imaging Platforms

1.Quantitative Analysis & Reporting

2.Tissue Evaluation & Analysis

3.Qualitative & Semi-Quantitative Analysis

4.Scientific & Regulatory Support

1.Isolation, Culture & Identification

2.Biochemical & Phenotypic Characterization

3.Antimicrobial & Antibiotic Evaluation

4.Mechanism of Action & Antimicrobial Resistance

5.Applied & Industrial Microbiology Services

1.Plant Extraction

2.Plant Extract Drying

3.Essential Oil Synthesis

4.Nanoparticle Synthesis

5.Exosome Isolation

Visionofresearch

Product-Specific Analytical Development

Product-Specific Assays represent one of the most critical components of the preclinical testing framework. These modules are not designed to assess safety, therapeutic efficacy, or PK/PD parameters; instead, they focus exclusively on direct, analytical, and mechanistic evaluation of the drug itself.

These assays investigate the intrinsic properties of the molecule, including:

  • how biologically active the drug is?
  •  whether it truly binds to its intended target?
  •  how stable it remains under various physicochemical conditions?
  •  and how much of its therapeutic activity can be demonstrated at the cellular level?

Thus, while Safety Assays reveal how the body reacts to the drug, and Efficacy Assays demonstrate what the drug does to the disease, Product-Specific Assays define the drug’s identity, quality, strength, stability, and mechanistic behavior in a direct and scientifically quantifiable manner.

The outputs of this package consist of six essential analytical modules

Send a Message

Request a Call Back

    Veterinary Industry Innovation

    1

    Custom Drug Quantification Method Development

     This module is required when the molecule is novel, peptide-based, nanoparticle-based, or non-antibody in nature, meaning no commercial assay or established global method exists for its measurement. A validated analytical method is fundamental for accurate PK/PD studies.

    Tests and activities (with reasons):

    1. Custom ELISA development (to generate antigen/antibody pairs when no commercial kit exists)
    2. HPLC or LC–MS/MS method development (for sensitive and specific quantification of novel molecules)
    3. Standard curve & calibration curve construction (to enable accurate quantitative measurement)
    4. Full method validation: linearity, sensitivity, accuracy, precision, LLOQ/HLOQ, recovery (to meet regulatory validation criteria)
    5. Matrix effect & biological stability assessment (to ensure method reliability in serum/plasma)
    Learn more
    Veterinary Industry Innovation

    2

    Target Engagement & Pathway Modulation Assays

    These assays establish mechanistic proof that the drug interacts with the target pathway an essential requirement for validating therapeutic relevance.

    Tests (with reasons):

    1. Western Blot (p-AKT, p-ERK, STATs) (to confirm pathway activation or inhibition)
    2. ELISA / Multiplex biomarkers (to quantify downstream signaling molecules)
    3. Flow Cytometry for receptor occupancy (to measure % of receptors bound by the drug)
    4. Receptor-binding / occupancy assays (to demonstrate direct interaction with the biological target)
    5. Signal-pathway activity reporting (to map molecular alterations following drug exposure)
    Learn more
    Veterinary Industry Innovation

    3

    Physicochemical Stability & Degradation Profiling

    Critical for peptides, proteins, nanoparticles, and sensitive small molecules. Required for quality control and regulatory submission.

    Tests (with reasons):

    1. Stress stability testing at 4°C / 25°C / 37°C (to assess temperature-dependent degradation)
    2. DLS, SDS-PAGE, SEC-HPLC (to detect aggregation and structural changes)
    3. Nanoparticle size distribution analysis (to evaluate physical stability)
    4. Degradation pathway analysis (to identify breakdown products and mechanisms)
    5. Serum/Plasma stability testing (to assess biological stability)
    Learn more
    Veterinary Industry Innovation

    4

    Functional Potency & Biological Activity Assessment

    These assays determine whether the drug is capable of producing the expected cellular or molecular response and are core to establishing the Mechanism of Action (MoA).

    Tests (with reasons):

    1. Cell-based potency assays (to measure biological activity in functional cell models)
    2. cAMP assay (to evaluate GPCR/GLP-1 signaling activity)
    3. Luciferase reporter assays (to monitor transcriptional or inflammatory pathways)
    4. Functional cellular assays (to assess direct activation/inhibition of target pathways)
    5. Enzymatic activity assays (to measure biochemical effects mediated by the drug)
    Learn more
    Veterinary Industry Innovation

    5

    Receptor Binding Kinetics & Affinity Measurement

    Affinity parameters (Kd, EC50, IC50) are essential for scientific publications, investor discussions, and regulatory evaluation.

    Tests (with reasons):

    1. Surface Plasmon Resonance (SPR) (to measure real-time binding kinetics)
    2. Biolayer Interferometry (BLI) (label-free affinity quantification)
    3. Radioligand binding assays (high-sensitivity receptor binding assessment)
    4. Kd, EC50, IC50 calculations (to quantify binding strength and functional potency)
    5. kon / koff kinetic analysis (to determine association/dissociation speed)
    Learn more